Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Elagolix sodium (NBI-56418 sodium) is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 61.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 175.00 | |
50 mg | In stock | $ 287.00 | |
100 mg | In stock | $ 447.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | Elagolix sodium (NBI-56418 sodium) is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM, respectively). |
Targets&IC50 | GnRHR:0.25 nM, GnRHR:3.7 nM |
In vivo | Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain[1] |
Synonyms | NBI-56418 sodium |
Molecular Weight | 653.57 |
Formula | C32H29F5N3NaO5 |
CAS No. | 832720-36-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (76.50 mM)
H2O: 50 mg/mL (76.50 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Elagolix sodium 832720-36-2 GPCR/G Protein GNRH Receptor Gonadotropin releasing hormone receptor inhibit NBI-56418 GnRH Receptor NBI 56418 Elagolix GNRHR Inhibitor NBI-56418 sodium NBI56418 inhibitor